Inquiry Basket
CAS No.:
Cat No.: BADC-00843
Purity: >99%
4.5 
D8-MMAD is a synthetic ADC payload with potent microtubule inhibitory activity, causing cancer cell cycle arrest and apoptosis. As an ADC cytotoxin, it enhances therapeutic efficacy of antibody-drug conjugates in resistant tumors.
Structure of
* For research and manufacturing use only. We do not sell to patients.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
| Catalog | Product Name | CAS | Inquiry |
|---|---|---|---|
| BADC-00026 | Mc-MMAD | 1401963-15-2 | |
| BADC-00024 | Vc-MMAD | 1401963-17-4 | |
| BADC-00016 | Vat-Cit-PAB-MMAD | 1415329-13-3 | |
| BADC-00310 | MMAD hydrochloride | 173441-26-4 | |
| BADC-00309 | MMAD | 203849-91-6 | |
| BADC-00803 | Cys-mcMMAD | ||
| BADC-00728 | OSu-Glu-vc-PAB-MMAD | ||
| BADC-00736 | MC-va-PAB-MMAD | ||
| BADC-00739 | MC-vc-PAB-MMAD | ||
| BADC-00757 | DBCO-PEG4-vc-PAB-MMAD |
D8-MMAD
Required fields are marked with *
D8-MMAD
Required fields are marked with *
Contact our experts today for pricing and comprehensive details on our ADC offerings.
From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.
Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.
Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.
